373 related articles for article (PubMed ID: 33544511)
1. COVID-19 and cardiovascular disease: a review of current knowledge.
Pal A; Ahirwar AK; Sakarde A; Asia P; Gopal N; Alam S; Kaim K; Ahirwar P; Sorte SR
Horm Mol Biol Clin Investig; 2021 Feb; 42(1):99-104. PubMed ID: 33544511
[TBL] [Abstract][Full Text] [Related]
2. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme as a new immunologic target for the new SARS-CoV-2.
Hallaj S; Ghorbani A; Mousavi-Aghdas SA; Mirza-Aghazadeh-Attari M; Sevbitov A; Hashemi V; Hallaj T; Jadidi-Niaragh F
Immunol Cell Biol; 2021 Feb; 99(2):192-205. PubMed ID: 32864784
[TBL] [Abstract][Full Text] [Related]
4. Association of ACE inhibitors and angiotensin type II blockers with ACE2 overexpression in COVID-19 comorbidities: A pathway-based analytical study.
Parit R; Jayavel S
Eur J Pharmacol; 2021 Apr; 896():173899. PubMed ID: 33508281
[TBL] [Abstract][Full Text] [Related]
5. Overview of Covid-19 Regarding the Cardiovascular Situation in the Light of Current Reports.
Aydin S; Akkoc RF; Aydin S
Cardiovasc Hematol Disord Drug Targets; 2020; 20(3):181-184. PubMed ID: 32611305
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients.
Semenzato L; Botton J; Drouin J; Baricault B; Vabre C; Cuenot F; Penso L; Herlemont P; Sbidian E; Weill A; Dray-Spira R; Zureik M
Hypertension; 2021 Mar; 77(3):833-842. PubMed ID: 33423528
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019.
Suh SH; Ma SK; Kim SW; Bae EH
Korean J Intern Med; 2021 Mar; 36(2):247-262. PubMed ID: 33617712
[TBL] [Abstract][Full Text] [Related]
8. Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic.
Li Z; Xu X; Yang M; Feng J; Liu C; Yang C
Aging (Albany NY); 2020 Nov; 12(23):24453-24461. PubMed ID: 33197881
[TBL] [Abstract][Full Text] [Related]
9. Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis.
Seeherman S; Suzuki YJ
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562193
[TBL] [Abstract][Full Text] [Related]
10. ACE2: from protection of liver disease to propagation of COVID-19.
Warner FJ; Rajapaksha H; Shackel N; Herath CB
Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Manifestations of COVID-19 Infection.
Magadum A; Kishore R
Cells; 2020 Nov; 9(11):. PubMed ID: 33228225
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2.
Buckley LF; Cheng JWM; Desai A
J Cardiovasc Pharmacol; 2020 Jun; 75(6):526-529. PubMed ID: 32301766
[TBL] [Abstract][Full Text] [Related]
13. Relationship Between COVID-19 and Angiotensin-Converting Enzyme 2: A Scoping Review.
Shojaee A; Vahedian-Azimi A; Faizi F; Rahimi-Bashar F; Shahriary A; Galeh HEG; Nehrir B; Guest PC; Sahebkar A
Adv Exp Med Biol; 2021; 1321():53-68. PubMed ID: 33656713
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases.
Sharma RK; Li J; Krishnan S; Richards EM; Raizada MK; Mohandas R
Clin Sci (Lond); 2021 Jan; 135(1):1-17. PubMed ID: 33399851
[TBL] [Abstract][Full Text] [Related]
15. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.
Sama IE; Ravera A; Santema BT; van Goor H; Ter Maaten JM; Cleland JGF; Rienstra M; Friedrich AW; Samani NJ; Ng LL; Dickstein K; Lang CC; Filippatos G; Anker SD; Ponikowski P; Metra M; van Veldhuisen DJ; Voors AA
Eur Heart J; 2020 May; 41(19):1810-1817. PubMed ID: 32388565
[TBL] [Abstract][Full Text] [Related]
16. ACE2: The Major Cell Entry Receptor for SARS-CoV-2.
Scialo F; Daniele A; Amato F; Pastore L; Matera MG; Cazzola M; Castaldo G; Bianco A
Lung; 2020 Dec; 198(6):867-877. PubMed ID: 33170317
[TBL] [Abstract][Full Text] [Related]
17. Focus on clinical practice: angiotensin-converting enzyme 2 and corona virus disease 2019: pathophysiology and clinical implications.
Barillà F; Bassareo PP; Calcaterra G; Romeo F; Mehta JL
J Cardiovasc Med (Hagerstown); 2020 Sep; 21(9):630-633. PubMed ID: 32740495
[TBL] [Abstract][Full Text] [Related]
18. Renin-angiotensin system and SARS-CoV-2 interaction: underlying mechanisms and potential clinical implications.
Hrenak J; Zorad S; Simko F
Gen Physiol Biophys; 2020 May; 39(3):203-204. PubMed ID: 32525813
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 and cardiovascular disease.
Guijarro C
Clin Investig Arterioscler; 2020; 32(6):263-266. PubMed ID: 33213825
[No Abstract] [Full Text] [Related]
20. ACE2 role in SARS-CoV-2 infectivity and Covid-19 severity.
Azizan E; Brown M
Malays J Pathol; 2020 Dec; 42(3):363-367. PubMed ID: 33361716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
